In a small observational study, telitacicept use was associated with improvement in renal and hematologic parameters in patients with lupus nephritis and nephrotic syndrome. Telitacicept use is ...
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...
In a small study, proteinuria improved even in patients with nephrotic syndrome and lupus nephritis. Belimumab appears similarly effective and well tolerated in patients with lupus nephritis (LN) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results